Australia markets close in 15 minutes

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1500-0.0100 (-0.86%)
At close: 04:00PM EST
1.1300 -0.02 (-1.74%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 62.14M
Enterprise value -76.95M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.27
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.71

Trading information

Stock price history

Beta (5Y monthly) 1.51
52-week change 3-83.52%
S&P500 52-week change 3-8.38%
52-week high 311.5200
52-week low 30.2900
50-day moving average 30.5684
200-day moving average 31.5747

Share statistics

Avg vol (3-month) 36.97M
Avg vol (10-day) 38.27M
Shares outstanding 557.54M
Implied shares outstanding 6N/A
Float 853.22M
% held by insiders 10.06%
% held by institutions 117.88%
Shares short (29 Dec 2022) 43.36M
Short ratio (29 Dec 2022) 40.32
Short % of float (29 Dec 2022) 45.85%
Short % of shares outstanding (29 Dec 2022) 45.84%
Shares short (prior month 29 Nov 2022) 41.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:32
Last split date 316 May 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.74%
Return on equity (ttm)-50.14%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -108.4M
Net income avi to common (ttm)-112.35M
Diluted EPS (ttm)-7.5030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.98M
Total cash per share (mrq)2.43
Total debt (mrq)886k
Total debt/equity (mrq)0.39
Current ratio (mrq)11.33
Book value per share (mrq)4.29

Cash flow statement

Operating cash flow (ttm)-98.2M
Levered free cash flow (ttm)-123.75M